A database to collect in a single web-based resource basic and clinical information, and data about any allergenic organism and its molecular structures capable to induce an IgE-mediated disease. Allergome main goal is to collect a list of allergenic sources and molecules by using the widest selection criteria and sources. A further development of the Allergome platform has been represented by the Real Time Monitoring of IgE sensitization module (ReTiME) that allows uploading of raw data from both in vivo and in vitro testing, thus representing the first attempt to have IT applied to allergy data mining.
Allergy Data Laboratories sc, Italy; Center for Clinical and Experimental Allergology, Rome, Italy; Panservice srl, Latina, Italy
Allergome funding source(s)
The Allergome platform is an independent project managed and financially supported by Allergy Data Laboratories sc, a non-for-profit company. The project is now also supported by unrestricted grants from Phadia (Uppsala, Sweden), Indoor Biotechnologies (Cardiff, United Kingdom), Laboratorios Leti (Barcelona, Spain), Siemens Medical Solutions Diagnostics (Los Angeles, CA, USA), Allergopharma (Reinbek, Germany), VBC-Genomics (Vienna, Austria), UCB Pharma (Pianezza, Italy), Biomay (Vienna, Austria), Stallergenes (Antony, France). The Allergome project receives funding from the following institutions: University of Nebraska, ‘‘Food Allergy Research and Resource Program’’ (Lincoln, NE, USA), University of Salzburg, Priority Programme ‘‘BioScience and Health’’ (Salzburg, Austria), Institute for Research in Biomedicine (Bellinzona, Switzerland), University ‘‘Gabriele D’Annunzio’’ di Chieti e Pescara, Allergy and Clinical Immunology Section (Chieti, Italy), and IDI-IRCCS (Rome, Italy).